Literature DB >> 12679435

Thyroid hemiagenesis: prevalence in normal children and effect on thyroid function.

Raffaella Maiorana1, Anna Carta, Giuseppina Floriddia, Daniela Leonardi, Massimo Buscema, Lidia Sava, Francesca Calaciura, Riccardo Vigneri.   

Abstract

Thyroid hemiagenesis prevalence was studied by neck ultrasound examination in 24,032 unselected 11- to 14-yr-old schoolchildren from southeastern Sicily. Twelve cases of thyroid hemiagenesis were identified, with a prevalence of 0.05%. The female to male ratio was 1:1.4. Thyroid hemiagenesis was always due to the absence (11 cases) or severe hypoplasia (1 case) of the left lobe. The hemiagenetic thyroid volume was within the normal total thyroid volume range normalized to age in 4 of 12 cases, enlarged in 3, and significantly reduced in 5. Thyroid function (thyroid hormones and TSH, both basal and 30 min after administration of 200 micro g TRH, iv) was evaluated in 9 of 12 children and was always within the normal range. However, children with thyroid hemiagenesis had an average serum TSH significantly higher than that of 18 matched controls (2.8 +/- 0.6 vs. 1.9 +/- 0.5 mU/liter; P < 0.001). This study confirms that thyroid hemiagenesis is nearly always due to left lobe defect, and that its prevalence is similar to the cumulative prevalence of thyroid agenesis and ectopia. Compensatory hypertrophy of the residual thyroid lobe occurs in most, but not all, cases and is due to thyroid tissue overstimulation by TSH. The high risk of goiter and hypothyroidism suggests systematic follow-up of all identified cases of thyroid hemiagenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679435     DOI: 10.1210/jc.2002-021574

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  Detection and treatment of congenital hypothyroidism.

Authors:  Annette Grüters; Heiko Krude
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Unusual thyroid constellation in Down syndrome: congenital hypothyroidism, Graves' disease, and hemiagenesis in the same child.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  J Pediatr Endocrinol Metab       Date:  2009-03       Impact factor: 1.634

Review 3.  The molecular causes of thyroid dysgenesis: a systematic review.

Authors:  I C Nettore; V Cacace; C De Fusco; A Colao; P E Macchia
Journal:  J Endocrinol Invest       Date:  2013-05-22       Impact factor: 4.256

4.  Thyroid hemiagenesis and incidentally discovered papillary thyroid cancer: case report and review of the literature.

Authors:  A M Pizzini; G Papi; S Corrado; C Carani; E Roti
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

5.  A UK reported case of Graves' disease with thyroid hemiagenesis.

Authors:  Jack Faulkner; Kiran Varadharajan; Natasha Choudhury
Journal:  BMJ Case Rep       Date:  2019-08-02

6.  Bilobar thyroid agenesis with primary hyperparathyroidism: report of a case.

Authors:  Turgay Şimşek; Nuh Zafer Cantürk; Zeynep Cantürk; Yeşim Gürbüz
Journal:  Surg Today       Date:  2014-08-06       Impact factor: 2.549

7.  Thyroid hemiagenesis associated with multinodular goiter and Hashimoto's thyroiditis.

Authors:  Daniela Bosco; A Cammarata; R Cannarella; R Latino; R Lanteri; A Di Cataldo; A Calogero
Journal:  G Chir       Date:  2017 Nov-Dec

8.  Thyroid hemiagenesis: report of a case and review of literature.

Authors:  Sarah Peña; Hugh Robertson; Rohan R Walvekar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-30

9.  Left thyroid hemiagenesis in a patient with primary hyperparathyroidism.

Authors:  Siddek Isreb; Faisal Alem; David Smith
Journal:  BMJ Case Rep       Date:  2010-08-06

10.  Clinical and epidemiological characteristics of thyroid hemiagenesis: ultrasound screening in patients with thyroid disease and normal population.

Authors:  Alptekin Gursoy; Cuneyd Anil; Asli Dogruk Unal; Asli Nar Demirer; Neslihan Bascil Tutuncu; Murat Faik Erdogan
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.